FindTrial
Sign In

Whole exome sequencing in the application of the recurrent spontaneous abortion (URSA)

Whole exome sequencing in the application of the recurrent spontaneous abortion (URSA)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014646
Enrollment
Unknown
Registered
2018-01-26
Start date
2018-02-01
Completion date
Unknown
Last updated
2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Genetic diseases

Interventions

unexplained recurrent spontaneous abortion:whole exome sequencing

Sponsors

Peking University Third Hospital Reproductive Medicial Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Abortion 3 times or more than 3 times; Husband and wife and fetal chromosome karyotypes normal

Exclusion criteria

Exclusion criteria: parental and embryo chromosomal abnormalities, endocrinological dysfunctions, immunological diseases, uterine structural abnormalities, prothrombotic states, infections and environmental factors.

Design outcomes

Primary

MeasureTime frame
Gene;—

Countries

China

Contacts

Public ContactQiao Jie

Peking University Third Hospital Reproductive Medicial Center

jie.qiao@263.net+86 18515933388

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026